Abstract
Drug economy has always been and will continue to be important for hospitals. Substitution, as an aid to economy, requires reappraisal in the light of our developing knowledge of formulation and resultant bio-availability. The continued unqualified use of generic names in teaching and prescribing requires re-examination as a part of the problem and this highlights the need for better communication between medicine and pharmacy.
Full text
PDF


